Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Gen AI Powered Behavioral Support Plus Chewing Gum Intervention for Construction Workers Who Smoke

14 juni 2026 uppdaterad av: Prof. Wang Man-Ping, The University of Hong Kong

Build to Quit 「築建無煙」: Gen AI Powered Behavioral Support Plus Chewing Gum Intervention for Construction Workers Who Smoke: A Pragmatic, Pilot, Cluster Randomized Controlled Trial

The goal of this pilot trial is to learn if 1-week NRT sampling, 3-week chewing gum, and 12-week chatbot-delivered instant messaging support works to help smoking cessation in construction workers who smoke. It will also learn about the feasibility, acceptability, and preliminary effectiveness of delivering the comprehensive intervention in construction settings. The main questions it aims to answer are:

  1. Will the integrated intervention, comprising NRT sampling, chewing gum, and chatbot-delivered instant messaging support, show feasibility, acceptability, and appropriateness for delivery in construction worksite settings?
  2. Will participants who receive the comprehensive intervention have a higher validated abstinence rate than those who receive NRT sampling alone?

Researchers will compare the integrated intervention, comprising NRT sampling, chewing gum, and chatbot-delivered instant messaging support, to the standard care group (NRT sampling alone) to see if the integrated intervention works to promote smoking cessation.

Participants in the intervention group will receive:

  1. AWARD advice and brief video
  2. 1-week NRT sampling
  3. 3-week chewing gum
  4. 12-week chatbot-based instant messaging support (via WhatsApp)

Studieöversikt

Status

Har inte rekryterat ännu

Betingelser

Intervention / Behandling

Detaljerad beskrivning

Hong Kong has achieved a sustained reduction in daily cigarette smoking, from 23.3% in the early 1980s to 8.5% in 2025. However, the current prevalence remains above the Government's Towards 2025 target of 7.8%, indicating the need for continued and targeted cessation efforts. The construction industry represents a particularly important setting for intervention, as recent legislative amendments to designate construction sites as no-smoking areas have further strengthened the policy basis for promoting smoke-free worksites.

Construction workers (CWs) are a high-priority population for smoking cessation because they have consistently higher smoking prevalence than many other occupational groups and the general population. In Hong Kong, a workplace health study found that 45% of construction workers were daily smokers, nearly twice the prevalence among office clerks/professionals. For CWs, smoking may compound existing occupational health risks by increasing susceptibility to respiratory and cardiovascular diseases in a physically demanding and dust-exposed work environment.

This study proposes a comprehensive worksite-targeted smoking cessation intervention model for CWs who smoke in Hong Kong, integrating NRT sampling, chewing gum support, and chatbot-delivered instant messaging. NRT is an evidence-based pharmacotherapy for reducing nicotine withdrawal symptoms and supporting smoking abstinence, and has been widely used in community-based cessation interventions. For CWs, short-term NRT sampling may provide immediate access to evidence-based pharmacological support, reduce early withdrawal symptoms, and lower the initial barrier to treatment uptake in a worksite setting. Chewing gum may complement NRT sampling by serving as a low-cost behavioral substitute for smoking, particularly by replacing the hand-to-mouth and oral routines associated with cigarette use. Chatbot-delivered instant messaging support can further extend the intervention beyond the worksite by providing 24/7 support, reminders for NRT and chewing gum use, and real-time assistance during cravings or high-risk smoking situations.

Studietyp

Interventionell

Inskrivning (Beräknad)

200

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

  • Namn: Man Ping Wang, PhD
  • Telefonnummer: +852 3917 6636
  • E-post: mpwang@hku.hk

Studera Kontakt Backup

Studieorter

  • Hong Kong
    • Hong Kong
      • Hong Kong, Hong Kong, Hong Kong, 999077
        • Hong Kong Council on Smoking and Health (COSH)
        • Kontakt:
          • Fung Wong
          • Telefonnummer: +852 2180 5186
        • Underutredare:
          • Tai Hing Lam, MD
        • Underutredare:
          • Tzu Tsun Luk, PhD
        • Underutredare:
          • Xiaoyun Xie, MPH
        • Underutredare:
          • Mengyao Li, Mphil
        • Underutredare:
          • Ziqiu Guo, PhD
        • Underutredare:
          • Yilan Wu, Mphil

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Beskrivning

Inclusion Criteria:

  1. Hong Kong residents aged 18 or above
  2. Smoke at least one cigarette per day in the preceding 3-month
  3. Able to communicate in Cantonese (including reading and writing Chinese)
  4. Saliva cotinine 30 ng/ml or above
  5. Intent to quit / reduce smoking
  6. Have instant messaging tool (WhatsApp) installed
  7. Able to use instant messaging tool (e.g., WhatsApp) for communication.

Exclusion Criteria:

  1. Smokers who are participating in other smoking cessation programmes
  2. Smokers who are using any smoking cessation medication
  3. Smokers who are presenting with the following oral diseases, including recent oral surgery or tooth extraction, unstable dentures, significant tooth mobility or advanced periodontal disease, temporomandibular pain or dysfunction, or painful oral mucosal lesions

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Hälsovårdsforskning
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Insatsgrupp
Beteende: Självhjälpshäfte om rökavvänjning
Innehållet innehåller bland annat information om fördelarna med att sluta, röka och sjukdomar, metoder för att sluta, hur man hanterar abstinensbesvär, förklaring om att sluta m.m.
Beteende: Utmärkelsen råd
Prisutdelar inkluderar fråga om rökhistoria, varna för den höga risken, rekommendera att sluta, hänvisa rökare till rökavvänjningstjänster (med ett remisskort) och göra det igen.
Beteende: Remisskort
Innehållet består av kort information och en höjdpunkt i befintliga rökavvänjningstjänster, kontaktmetoder, motivationsinformation och starka stödmeddelanden eller slagord.
Beteende: Brief leaflet on health warning and smoking cessation
The contents of the leaflet include (1) highlights of the absolute risk of death due to smoking; (2) the whole list of diseases caused by active and secondhand smoking; (3) ten horrible pictorial warnings of health consequences of smoking and second-hand smoking in one page to maximize the impacts; (4) benefits of SC and (5) simple messages to encourage participants to quit smoking.
Läkemedel: 1-week nicotine gum
Participants in both group will receive a 1-week supply of free nicotine gum (2 mg or 4 mg). The dosage of nicotine gum will be guided by participants' daily cigarette consumption, in accordance with recommendations from the Department of Health. Research assistants will explain the benefits of NRT for smoking cessation, provide instructions on the correct use of nicotine gum, encourage participants to continue using nicotine gum after completing the free sample where appropriate, and advise participants to reduce smoking or make a quit attempt when using NRT.
Beteende: 3-week chewing gum
Participants in the intervention group will receive 6 packs of chewing gum at baseline (2 packs per week). Chewing gum will be presented as a practical strategy to replace the hand-to-mouth and oral routines associated with smoking, particularly during work breaks, after meals, in other smoking-related situations at construction sites, or when participants are unwilling to use nicotine gum.
Beteende: 12-week chatbot-based instant messaging support
Participants in the intervention group will receive 12 weeks of instant messaging support delivered by the LLM-based chatbot accessible via WhatsApp platform. The chatbot, powered by Claude model (or more advanced model available) using prompt-engineering and agent-based techniques, will deliver theory-based and structured intervention alongside freeform, on-demand support. The structured intervention session deploys the 5As model (Ask, Advise, Assess, Assist, and Arrange follow-up) and 5Rs model (Relevance, Risks, Rewards, Roadblocks, Repetition), as used in our previous telephone-counselling trials and recommended by WHO for brief SC intervention.
Beteende: Brief video
Participants in both groups will receive a brief motivational video (15-second) via WhatsApp. The video will feature a construction worker who successfully quit smoking in our previous trial, providing a relatable peer role model for participants. The video will welcome participants to the programme, encourage them to make a quit attempt, and promote early use of nicotine gum as a practical strategy for managing cravings and supporting smoking cessation.
Aktiv komparator: Kontrollgrupp
Beteende: Självhjälpshäfte om rökavvänjning
Innehållet innehåller bland annat information om fördelarna med att sluta, röka och sjukdomar, metoder för att sluta, hur man hanterar abstinensbesvär, förklaring om att sluta m.m.
Beteende: Utmärkelsen råd
Prisutdelar inkluderar fråga om rökhistoria, varna för den höga risken, rekommendera att sluta, hänvisa rökare till rökavvänjningstjänster (med ett remisskort) och göra det igen.
Beteende: Remisskort
Innehållet består av kort information och en höjdpunkt i befintliga rökavvänjningstjänster, kontaktmetoder, motivationsinformation och starka stödmeddelanden eller slagord.
Beteende: Brief leaflet on health warning and smoking cessation
The contents of the leaflet include (1) highlights of the absolute risk of death due to smoking; (2) the whole list of diseases caused by active and secondhand smoking; (3) ten horrible pictorial warnings of health consequences of smoking and second-hand smoking in one page to maximize the impacts; (4) benefits of SC and (5) simple messages to encourage participants to quit smoking.
Läkemedel: 1-week nicotine gum
Participants in both group will receive a 1-week supply of free nicotine gum (2 mg or 4 mg). The dosage of nicotine gum will be guided by participants' daily cigarette consumption, in accordance with recommendations from the Department of Health. Research assistants will explain the benefits of NRT for smoking cessation, provide instructions on the correct use of nicotine gum, encourage participants to continue using nicotine gum after completing the free sample where appropriate, and advise participants to reduce smoking or make a quit attempt when using NRT.
Beteende: Brief video
Participants in both groups will receive a brief motivational video (15-second) via WhatsApp. The video will feature a construction worker who successfully quit smoking in our previous trial, providing a relatable peer role model for participants. The video will welcome participants to the programme, encourage them to make a quit attempt, and promote early use of nicotine gum as a practical strategy for managing cravings and supporting smoking cessation.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Biokemiskt validerad abstinens
Tidsram: 6 månaders uppföljning
Definierat som utandad CO-nivå <4ppm och salivkotininnivå ≤30 ng/ml
6 månaders uppföljning

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Biokemiskt validerad abstinens
Tidsram: 3 månaders uppföljning
Definierat som utandad CO-nivå <4ppm och salivkotininnivå ≤30 ng/ml
3 månaders uppföljning
Självrapporterad 7-dagars prevalensavhållighet
Tidsram: 3- och 6-månaders uppföljningar
Rökare som inte röker ens en puff under de sju dagarna före uppföljningen
3- och 6-månaders uppföljningar
Självrapporterad minskning
Tidsram: 1-, 2-, 3- och 6-månaders uppföljningar
Definieras av minst 50% minskning av baslinjen dagligen antal cigaretter
1-, 2-, 3- och 6-månaders uppföljningar
Självrapporterad användning av rökavvänjningstjänst
Tidsram: 1-, 2-, 3- och 6-månaders uppföljningar
Användning av rökavvänjningstjänst vid 1-, 2-, 3- och 6-månaders uppföljningar.
1-, 2-, 3- och 6-månaders uppföljningar
Family well-being
Tidsram: 3- and 6-month follow-ups
Family well-being will be assessed using the 3H scale, which measures perceived family health, happiness, and harmony on a 0-10 scale.
3- and 6-month follow-ups
Perceived family happiness
Tidsram: 3- and 6-month follow-ups
Perceived family happiness will be measured using a single-item self-reported family happiness scale ranging from 0 to 10.
3- and 6-month follow-ups

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Recruitment rate
Tidsram: Baseline
Defined as the number of participants divided by the number of eligible smokers
Baseline
Retention rate
Tidsram: 1-, 2-, 3- and 6-month follow-ups
Defined as the number of participants who completed the follow-up divided by the number of participants
1-, 2-, 3- and 6-month follow-ups
Acceptability of NRT sampling
Tidsram: 1-, 2-, 3- and 6-month follow-ups
Acceptability of NRT sampling will be assessed through 4 brief items (score range from 0 to10) on perceived usefulness for craving relief, perceived side effects, willingness to continue using NRT after the free sample, and overall satisfaction with the NRT gum.
1-, 2-, 3- and 6-month follow-ups
Acceptability of chewing gum
Tidsram: 1-, 2-, 3- and 6-month follow-ups
Acceptability of chewing gum will be assessed through 3 brief items (score range from 0 to 10) on perceived usefulness for behavioral substitution, perceived fit with construction worksite routines, and willingness to continue using chewing gum as a cessation aid.
1-, 2-, 3- and 6-month follow-ups
Self-reported adverse events
Tidsram: 1-, 2-, 3- and 6-month follow-ups
Self-reported adverse events related to nicotine gum and chewing gum will be assessed using a binary question: "Have you experienced any adverse events when using nicotine gum or chewing gum?"
1-, 2-, 3- and 6-month follow-ups
Chatbot usability
Tidsram: 3-month follow-up
Chatbot usability will be evaluated using the 11-item Bot Usability Scale (BUS), which assesses perceived effectiveness, efficiency, and satisfaction. The score of the Bot Usability Scale ranges from 0 to 100, with the higher score indicating more usability of the chatbot.
3-month follow-up

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

The University of Hong Kong

Utredare

  • Huvudutredare: Man Ping Wang, PhD, The University of Hong Kong

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

20 juni 2026

Primärt slutförande (Beräknad)

31 maj 2027

Avslutad studie (Beräknad)

30 juni 2027

Studieregistreringsdatum

Först inskickad

9 juni 2026

Först inskickad som uppfyllde QC-kriterierna

9 juni 2026

Första postat (Faktisk)

15 juni 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

17 juni 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

14 juni 2026

Senast verifierad

1 juni 2026

Mer information

Termer relaterade till denna studie

Nyckelord

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • Build to Quit

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera